Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Castration-Resistant Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

    Contact: Study coordinator (Site Public Contact) · gingerreeves@uabmc.edu
    Contact: Principal Investigator (Joelle Hamilton)
  • Banner University Medical Center - Tucson, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Edward P. Gelmann)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Edward P. Gelmann)
  • Enloe Medical Center, Chico, California, United States

    Contact: Study coordinator (Site Public Contact) · 530-332-4700
    Contact: Principal Investigator (Nicholas Mitsiades)
  • UC San Diego Health System - Encinitas, Encinitas, California, United States

    Contact: Study coordinator (Site Public Contact) · 760-536-7700
    Contact: Principal Investigator (Rana R. McKay)
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Arash Rezazadeh Kalebasty)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Site Public Contact) · cancercto@ucsd.edu · 858-822-5354
    Contact: Principal Investigator (Rana R. McKay)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Arash Rezazadeh Kalebasty)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · 916-734-3089
    Contact: Principal Investigator (Nicholas Mitsiades)
  • UC San Diego Medical Center - Hillcrest, San Diego, California, United States

    Contact: Study coordinator (Site Public Contact) · rhabbaba@health.ucsd.edu
    Contact: Principal Investigator (Rana R. McKay)
  • UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 719-365-2406
    Contact: Principal Investigator (Steven R. Schuster)
  • Memorial Hospital North, Colorado Springs, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 719-364-6700
    Contact: Principal Investigator (Steven R. Schuster)
  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Steven R. Schuster)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Steven R. Schuster)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Steven R. Schuster)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Steven R. Schuster)
  • Stamford Hospital/Bennett Cancer Center, Stamford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 203-323-8944
    Contact: Principal Investigator (Anthony P. Gulati)
  • Beebe South Coastal Health Campus, Millville, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Beebe Health Campus, Rehoboth Beach, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Jupiter Medical Center, Jupiter, Florida, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@jupitermed.com · 561-263-5791
    Contact: Principal Investigator (Ryan H. Devine)
  • Tripler Army Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-433-6336
    Contact: Principal Investigator (Karen J. Shou)
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Canton, Canton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peru, Peru, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Memorial Hospital East, Shiloh, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · dschwab@wustl.edu · 314-747-9912
    Contact: Principal Investigator (Eric M. Knoche)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Illinois CancerCare - Washington, Washington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · katherine-daprile@uiowa.edu · 563-355-7733
    Contact: Principal Investigator (Fernando Maciel Barbosa)
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (Fernando Maciel Barbosa)
  • University of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Elizabeth M. Wulff)
  • The University of Kansas Cancer Center - Olathe, Olathe, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · OlatheCCResearch@kumc.edu · 913-588-1569
    Contact: Principal Investigator (Elizabeth M. Wulff)
  • University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Elizabeth M. Wulff)
  • University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-295-8000
    Contact: Principal Investigator (Elizabeth M. Wulff)
  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Elizabeth M. Wulff)
  • Saint Elizabeth Healthcare Edgewood, Edgewood, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · Kristi.Curtsinger@stelizabeth.com · 859-301-4730
    Contact: Principal Investigator (Matthew Kurian)
  • Saint Elizabeth Healthcare Fort Thomas, Fort Thomas, Kentucky, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • Dana-Farber Cancer Institute at Foxborough, Foxborough, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-338-7425
    Contact: Principal Investigator (Daniel Roberts)
  • Dana Farber-Merrimack Valley, Methuen, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-338-7425
    Contact: Principal Investigator (Pedro M. Sanz-Altamira)
  • Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-332-4294
    Contact: Principal Investigator (Daniel E. Fein)
  • Dana-Farber/Brigham and Women's Cancer Center at South Shore, South Weymouth, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 781-624-5000
    Contact: Principal Investigator (Thomas P. O'Connor)
  • Baystate Medical Center, Springfield, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · tamara.wrenn@baystatehealth.org · 413-794-3565
    Contact: Principal Investigator (John C. McCann)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • University of Michigan Health - Sparrow Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · harsha.trivedi@umhsparrow.org · 517-364-3712
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · coborncancercenter@centracare.com · 877-229-4907
    Contact: Principal Investigator (Donald J. Jurgens)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Eric M. Knoche)
  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia, Missouri, United States

  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Eric M. Knoche)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Eric M. Knoche)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Eric M. Knoche)
  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Eric M. Knoche)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Hackensack University Medical Center, Hackensack, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 551-996-2897
    Contact: Principal Investigator (Robert S. Alter)
  • Roswell Park Cancer Institute, Buffalo, New York, United States

    Contact: Study coordinator (Site Public Contact) · askroswell@roswellpark.org · 800-767-9355
    Contact: Principal Investigator (Ellis G. Levine)
  • Mount Sinai Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Eric J. Miller)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Catherine Fahey)
  • Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • MetroHealth Medical Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · ababal@metrohealth.org · 216-778-7559
    Contact: Principal Investigator (Joseph Attallah)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Timothy D. Gauntner)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Adanma Anji Ayanambakkam Attanathi)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · trials@ohsu.edu · 503-494-1080
    Contact: Principal Investigator (Alexandra O. Sokolova)
  • Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 800-836-0388
    Contact: Principal Investigator (Joyson Poulose)
  • Gibbs Cancer Center-Gaffney, Gaffney, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • Gibbs Cancer Center-Pelham, Greer, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • Spartanburg Medical Center, Spartanburg, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • SMC Center for Hematology Oncology Union, Union, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Kerry R. Schaffer)
  • Parkland Memorial Hospital, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-590-5582
    Contact: Principal Investigator (Joseph Vento)
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@utsouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Joseph Vento)
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Joseph Vento)
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Joseph Vento)
  • UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Suzanne.cole@utsouthwestern.edu · 972-669-7044
    Contact: Principal Investigator (Joseph Vento)
  • Bon Secours Memorial Regional Medical Center, Mechanicsville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Saint Francis Medical Center, Midlothian, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Richmond Community Hospital, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Saint Mary's Hospital, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Cancer Institute at Reynolds Crossing, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Anne_caramella@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · ctoclinops@vcu.edu
    Contact: Principal Investigator (John Melson)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (John Melson)
  • Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Alison K. Conlin)
  • West Virginia University Charleston Division, Charleston, West Virginia, United States

  • Edwards Comprehensive Cancer Center, Huntington, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Christina.Cole@chhi.org · 304-399-6566
    Contact: Principal Investigator (Toni O. Pacioles)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Joseph Edmund)
  • Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-257-5100
    Contact: Principal Investigator (Kathryn A. Bylow)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Kathryn A. Bylow)
  • Drexel Town Square Health Center, Oak Creek, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Kathryn A. Bylow)
  • Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Kathryn A. Bylow)
Study leads
  • Rana McKay, MD

    Study Chair

    Alliance for Clinical Trials in Oncology